Sulforaphane promotes natural killer cell-mediated anti-tumor immune responses partially via cGAS-STING pathway in classical Hodgkin lymphoma

Abstract excerpt

Classical Hodgkin lymphoma (cHL) is one of the most common lymphoma types with approximately 3 new cases per 100,000 population per year in the Western world. With the current treatment approaches of combined chemoradiotherapy, cHL can be cured in the majority of patients [ 1 ]; however, a proportion of patients succumb to the disease and the long-term treatment side effects remain a challenge for Hematologists...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoimmune and Inflammatory Disorders Research
• Share to IL-33, ST2, and ILC Pathways
• Share to Immune Cell Function and Interaction